Thrombophilia-related genetic variations in patients with pulmonary embolism in the main Teaching Hospital in Jordan

Saudi Medical Journal

Volumn 30, Issue 7, 2009, Pages 921-925

  Obeidat, Nathir M ^a   Awidi, Abdallah ^a   Sulaiman, Naef A ^a   Abu Khader, Ilham B ^a  

^a JORDAN UNIVERSITY HOSPITAL   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PROTHROMBIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; JORDAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; TEACHING HOSPITAL; THROMBOPHILIA;

ADULT; CASE-CONTROL STUDIES; FACTOR V; FEMALE; GENETIC VARIATION; HOSPITALS, TEACHING; HUMANS; JORDAN; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTHROMBIN; PULMONARY EMBOLISM; RISK FACTORS; THROMBOPHILIA;

EID: 70349512918     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ibrahim SA, Stone RA, Obrosky DS, Geng M, Fine MJ, Aujesky D. Thrombolytic therapy and mortality in patients with acute pulmonary embolism. Arch Intern Med 2008; 168: 2183-21890; discussion 2191-2192.
2. Gilmore R, Doyle M, Holden F, White B, O'Donnell J. Activated protein C resistance, factor V Leiden and assessment of thrombotic risk. Ir Med J 2008; 101: 256-257.
3. Saleh JA, Alasia DD. Acute pulmonary embolism: A review. Niger J Med 2007; 16: 11-17. Review. Erratum in: Niger J Med 2007; 16: 281.
4. Ivanov P, Komsa-Penkova R, Kovacheva K, Ivanov Y, Stoyanova A, Ivanov I, et al. Impact of thrombophilic genetic factors on pulmonary embolism: early onset and recurrent incidences. Lung 2008; 186: 27-36.
5. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: The longitudinal investigation of thromboembolism etiology. Arch Intern Med 2002; 162: 1182-1189.
6. Margaglione M, Brancaccio V, De Lucia D, Martinelli I, Ciampa A, Grandone E, et al. Inherited thrombophilic risk factors and venous thromboembolism: Distinct role in peripheral deep venous thrombosis and pulmonary embolism. Chest 2000; 118: 1234-1236.
7. Kruse L, Mitchell AM, Camargo CA Jr, Hernandez J, Kline JA. Frequency of thrombophilia-related genetic variations in patients with idiopathic pulmonary embolism in an urban emergency department. Clin Chem 2006; 52: 1026-1032.
8. White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107: I4-I8.
9. Heit JA, O'Fallon WM, Petterson TM, Lohse CM, Silverstein MD, Mohr DN, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: A population-based study. Arch Intern Med 2002; 162: 1245-1248.
10. Cushman M, Tsai AW, White RH, Heckbert SR, Rosamond WD, Enright P, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: The longitudinal investigation of thromboembolism etiology. Am J Med 2004; 117: 19-25.
11. Dowling NF, Austin H, Dilley A, Whitsett C, Evatt BL, Hooper WC. The epidemiology of venous thromboembolism in Caucasians and African-Americans: The GATE Study. J Thromb Haemost 2003; 1: 80-87.
12. Okumus G, Kiyan E, Arseven O, Tabak L, Diz-Kucukkaya R, Unlucerci Y, et al. Thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: The role in different clinical manifestations. Clin Appl Thromb Hemost 2008; 14: 168-173.
13. Lee CH, Hankey GJ, Ho WK, Eikelboom JW. Venous thromboembolism: diagnosis and management of pulmonary embolism. Med J Aust 2005; 182: 569-574.
14. Kline JA, Johnson CL, Webb WB, Runyon MS. Prospective study of clinician-entered research data in the emergency department using an internet-based system after the HIPAA Privacy Rule. BMC Med Inform Decis Mak 2004; 4: 17.
15. De Stefano V, Martinelli I, Rossi E, Battaglioli T, Za T, Mannuccio Mannucci P, et al. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. Br J Haematol 2006; 135: 386-391.
16. Huber S, Mcmasteter KJ, Voelkerding KV. Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of factor V leiden and prothrombin G20210A. J Mol Diagn 2000; 2: 153-157.
17. Yi P, Pogribny I, Jill James S. Multiplex PCR for simultaneous detection of 677 C->T and 1298 A->C polymorphisms in methylenetetrahydrofolate reductase gene for population studies of cancer risk. Cancer Lett 2002; 181: 209.
18. Eid SS, Shubeilat T. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR G677A among 594 thrombotic Jordanian patients. Blood Coagul Fibrinolysis 2005; 16: 417-421.
19. Pathare A, Al Kindi S, Al Haddabi H, Dennison D, Bayoumi R, Muralitharan S. Hereditary thrombophilia in ethnic Omani patients. Am J Hematol 2006; 81: 101-116.
20. Martinelli I, Battaglioli T, Razzari C, Mannucci PM. Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia. J Thromb Haemost 2007; 5: 98-101.